Santa Rosa Treatment Program Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Santa Rosa Treatment Program's estimated annual revenue is currently $4.3M per year.(i)
  • Santa Rosa Treatment Program's estimated revenue per employee is $241,500

Employee Data

  • Santa Rosa Treatment Program has 18 Employees.(i)
  • Santa Rosa Treatment Program grew their employee count by 0% last year.

Santa Rosa Treatment Program's People

NameTitleEmail/Phone
1
CEO~ Exceutive DirectorReveal Email/Phone
2
Case ManagerReveal Email/Phone
3
PresidentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.3M156-3%N/AN/A
#2
$148.5M440N/AN/AN/A
#3
$124.2M36846%N/AN/A
#4
$545.1M144217%N/AN/A
#5
$29.2M1086%N/AN/A
#6
$12.9M53N/AN/AN/A
#7
$1125.1M304110%$20.4MN/A
#8
$15.3M6315%N/AN/A
#9
$8.9M320%N/AN/A
#10
$4.3M180%N/AN/A
Add Company

What Is Santa Rosa Treatment Program?

Santa Rosa Treatment Program is a mental health care company based out of 1901 Cleveland Ave # B, Santa Rosa, California, United States.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$4.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Santa Rosa Treatment Program News

2022-04-20 - Most Overdose Deaths in Sonoma County Linked to Fentanyl

Counseling supervisor at Santa Rosa Treatment Program Jesse Collins told The Press Democrat that 98-percent of their patients have sought...

2022-04-19 - Supreme Court nixes appeal on Arkansas' Medicaid work ...

A federal judge had struck down the program that required certain ... Jim Wood (D-Santa Rosa), who chairs the Assembly Health Committee,...

2022-04-17 - Can the scourge of fentanyl be stopped? Here's how Sonoma ...

Sonoma County partners with a dozen treatment facilities, mostly in Santa Rosa, but independent centers also are available. A list of treatment...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M18-5%N/A
#2
$2.7M1927%N/A
#3
$1.3M1936%N/A
#4
$7.5M205%N/A
#5
$3.8M20-5%N/A